TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
LTRN

Lantern Pharma Inc

Healthcare · Biotechnology

0.8601$ -14.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow LTRN
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – –
– – +108.2% +99.6% +49.1% +45.0% +18.2% 0.0%
– -36.6% +912.4% -19.3% +23.5% -10.1% -31.3% -11.2%
– -36.6% +912.4% -2.3% +49.3% – – –
– -33.5% -619.2% – -202.0% – +314.1% -71.5%
– +0.0% +182.3% -4.0% +79.7% -32.7% -32.8% -86.4%
– -207.1% +182.3% +120,929.8% – -618.9% – +228.2%
– – +800.6% -103.6% +164.2% -79.9% – –
– +0.0% +0.0% -100.0% – – – –
– +445.9% +710.3% +168.0% -103.4% -77.1% – +2,145.9%
– – +2,187.2% +85.0% -144.4% – – –
– – – – – – – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?